During pregnancy, several physiological changes occur in the body. The tidal volume increases due to the relaxation of intercostal muscles and diaphragm caused by progesterone. However, constipation may occur due to the same hormone relaxing smooth muscles and the pressure of the growing baby. Micturition rate may either increase or decrease due to the mass effect of the baby on the bladder and surrounding structures.

Other changes include an increase in uterine size, cervical ectropion, and increased vaginal discharge due to increased mucus production. Cardiovascular changes include an increase in plasma volume, white cell count, platelets, ESR, cholesterol, and fibrinogen, while albumin, urea, and creatinine decrease. Progesterone-related effects include decreased blood pressure, bladder relaxation, biliary stasis, and increased tidal volume.

During pregnancy, a woman’s body undergoes various physiological changes. The cardiovascular system experiences an increase in stroke volume, heart rate, and cardiac output, while systolic blood pressure remains unchanged and diastolic blood pressure decreases in the first and second trimesters before returning to normal levels by term. The enlarged uterus may cause issues with venous return, leading to ankle swelling, supine hypotension, and varicose veins.

The respiratory system sees an increase in pulmonary ventilation and tidal volume, with oxygen requirements only increasing by 20%. This can lead to a sense of dyspnea due to over-breathing and a fall in pCO2. The basal metabolic rate also increases, potentially due to increased thyroxine and adrenocortical hormones.

Maternal blood volume increases by 30%, with red blood cells increasing by 20% and plasma increasing by 50%, leading to a decrease in hemoglobin levels. Coagulant activity increases slightly, while fibrinolytic activity decreases. Platelet count falls, and white blood cell count and erythrocyte sedimentation rate rise.

The urinary system experiences an increase in blood flow and glomerular filtration rate, with elevated sex steroid levels leading to increased salt and water reabsorption and urinary protein losses. Trace glycosuria may also occur.

Calcium requirements increase during pregnancy, with gut absorption increasing substantially due to increased 1,25 dihydroxy vitamin D. Serum levels of calcium and phosphate may fall, but ionized calcium levels remain stable. The liver experiences an increase in alkaline phosphatase and a decrease in albumin levels.

The uterus undergoes significant changes, increasing in weight from 100g to 1100g and transitioning from hyperplasia to hypertrophy. Cervical ectropion and discharge may increase, and Braxton-Hicks contractions may occur in late pregnancy. Retroversion may lead to retention in the first trimester but usually self-corrects.

The most frequent cause of infection is Staphylococcus aureus, which typically enters through damage to the nipple areolar complex caused by the infant’s mouth.

Breast Abscess: Causes and Management

Breast abscess is a condition that commonly affects lactating women, with Staphylococcus aureus being the most common cause. The condition is characterized by the presence of a tender, fluctuant mass in the breast.

To manage breast abscess, healthcare providers may opt for either incision and drainage or needle aspiration, with the latter typically done using ultrasound. Antibiotics are also prescribed to help treat the infection.

Breast abscess can be a painful and uncomfortable condition for lactating women. However, with prompt and appropriate management, the condition can be effectively treated, allowing women to continue breastfeeding their babies without any complications.

According to NICE guidelines, Labetalol is the preferred medication for treating hypertension in pregnant women. While Nifedipine is considered safe for use during pregnancy, it is not the first option. However, Ramipril and Candesartan should not be used during pregnancy due to potential risks.

Hypertension during pregnancy is a common condition that can be managed effectively with proper care. In normal pregnancy, blood pressure tends to decrease in the first trimester and then gradually increase to pre-pregnancy levels by term. However, if a pregnant woman develops hypertension, it is usually defined as a systolic blood pressure of over 140 mmHg or a diastolic blood pressure of over 90 mmHg. Additionally, an increase of more than 30 mmHg systolic or 15 mmHg diastolic from booking readings can also indicate hypertension.

After confirming hypertension, the patient should be categorized into one of three groups: pre-existing hypertension, pregnancy-induced hypertension (PIH), or pre-eclampsia. PIH, also known as gestational hypertension, occurs in 3-5% of pregnancies and is more common in older women. If a pregnant woman takes an ACE inhibitor or angiotensin II receptor blocker for pre-existing hypertension, it should be stopped immediately, and alternative antihypertensives should be started while awaiting specialist review.

Pregnancy-induced hypertension in association with proteinuria, which occurs in around 5% of pregnancies, may also cause oedema. The 2010 NICE guidelines recommend oral labetalol as the first-line treatment for hypertension during pregnancy. Oral nifedipine and hydralazine may also be used, depending on the patient’s medical history. It is important to manage hypertension during pregnancy effectively to reduce the risk of complications and ensure the health of both the mother and the baby.

Effective contraception with the progestogen-only pill can be achieved immediately if it is started on the first to the fifth day of menstruation. However, if it is started at any other time or if the patient is uncertain, it is recommended to use additional contraceptive methods like condoms or abstinence for the first 48 hours.

Counselling for Women Considering the Progestogen-Only Pill

Women who are considering taking the progestogen-only pill (POP) should receive counselling on various aspects of the medication. One of the most common potential adverse effects is irregular vaginal bleeding. It is important to note that the POP should be taken at the same time every day, without a pill-free break, unlike the combined oral contraceptive (COC).

When starting the POP, immediate protection is provided if commenced up to and including day 5 of the cycle. If started later, additional contraceptive methods such as condoms should be used for the first 2 days. If switching from a COC, immediate protection is provided if continued directly from the end of a pill packet.

In case of missed pills, if the delay is less than 3 hours, the pill should be taken as usual. If the delay is more than 3 hours, the missed pill should be taken as soon as possible, and extra precautions such as condoms should be used until pill taking has been re-established for 48 hours.

It is important to note that antibiotics have no effect on the POP, unless the antibiotic alters the P450 enzyme system. Liver enzyme inducers may reduce the effectiveness of the POP. In case of diarrhoea and vomiting, the POP should be continued, but it should be assumed that pills have been missed.

Finally, it is important to discuss sexually transmitted infections (STIs) with healthcare providers when considering the POP. By providing comprehensive counselling, women can make informed decisions about whether the POP is the right contraceptive choice for them.

The patient’s symptoms of vaginal bleeding, hyperthyroidism, and chest pain suggest a possible diagnosis of choriocarcinoma, which is characterized by significantly elevated levels of human chorionic gonadotropin in the serum. Metastases to the lungs may explain the chest pain, while the hyperthyroidism may be due to cross-reactivity between hCG and TSH receptors. Alkaline phosphatase is a tumor marker associated with bone and liver metastases as well as germ cell tumors, while chromogranin is a marker for neuroendocrine tumors that can occur in various parts of the body.

Gestational trophoblastic disorders refer to a range of conditions that originate from the placental trophoblast. These disorders include complete hydatidiform mole, partial hydatidiform mole, and choriocarcinoma. Complete hydatidiform mole is a benign tumor of trophoblastic material that occurs when an empty egg is fertilized by a single sperm that duplicates its own DNA, resulting in all 46 chromosomes being of paternal origin. Symptoms of this disorder include bleeding in the first or early second trimester, exaggerated pregnancy symptoms, a large uterus for dates, and high levels of human chorionic gonadotropin (hCG) in the blood. Hypertension and hyperthyroidism may also be present. Urgent referral to a specialist center is necessary, and evacuation of the uterus is performed. Effective contraception is recommended to avoid pregnancy in the next 12 months. About 2-3% of cases may progress to choriocarcinoma. In partial mole, a normal haploid egg may be fertilized by two sperms or one sperm with duplication of paternal chromosomes, resulting in DNA that is both maternal and paternal in origin. Fetal parts may be visible, and the condition is usually triploid.

Anastrozole and letrozole are medications that inhibit the production of oestrogen in peripheral tissues through the enzyme aromatase. These drugs are commonly used to treat breast cancer in postmenopausal women.

Trastuzumab is a monoclonal antibody that targets HER2 receptors on cancer cells, inhibiting their growth and proliferation. It is effective in treating HER2-positive breast cancer.

Fulvestrant is a selective oestrogen receptor degrader that breaks down oestrogen receptors without activating them, unlike tamoxifen. This leads to downregulation of the receptor.

Goserelin is an LHRH agonist that suppresses oestrogen production by the ovaries. It is often used as adjuvant therapy in premenopausal women.

Tamoxifen is an antagonist (and partial agonist) of the oestrogen receptor. It is particularly useful in treating oestrogen-receptor positive breast cancer, especially in patients who have not yet gone through menopause.

Anti-oestrogen drugs are used in the management of oestrogen receptor-positive breast cancer. Selective oEstrogen Receptor Modulators (SERM) such as Tamoxifen act as an oestrogen receptor antagonist and partial agonist. However, Tamoxifen may cause adverse effects such as menstrual disturbance, hot flushes, venous thromboembolism, and endometrial cancer. On the other hand, aromatase inhibitors like Anastrozole and Letrozole reduce peripheral oestrogen synthesis, which is important in postmenopausal women. Anastrozole is used for ER +ve breast cancer in this group. However, aromatase inhibitors may cause adverse effects such as osteoporosis, hot flushes, arthralgia, myalgia, and insomnia. NICE recommends a DEXA scan when initiating a patient on aromatase inhibitors for breast cancer.

The layers that will be encountered in the given scenario are as follows, in sequential order:

1. The skin layer
2. The dartos fascia and muscle layer
3. The external spermatic fascia layer
4. The cremasteric muscle and fascia layer
5. (Unknown or unspecified layer)

Anatomy of the Scrotum and Testes

The scrotum is composed of skin and dartos fascia, with an arterial supply from the anterior and posterior scrotal arteries. It is also the site of lymphatic drainage to the inguinal lymph nodes. The testes are surrounded by the tunica vaginalis, a closed peritoneal sac, with the parietal layer adjacent to the internal spermatic fascia. The testicular arteries arise from the aorta, just below the renal arteries, and the pampiniform plexus drains into the testicular veins. The left testicular vein drains into the left renal vein, while the right testicular vein drains into the inferior vena cava. Lymphatic drainage occurs to the para-aortic nodes.

The spermatic cord is formed by the vas deferens and is covered by the internal spermatic fascia, cremasteric fascia, and external spermatic fascia. The cord contains the vas deferens, testicular artery, artery of vas deferens, cremasteric artery, pampiniform plexus, sympathetic nerve fibers, genital branch of the genitofemoral nerve, and lymphatic vessels. The vas deferens transmits sperm and accessory gland secretions, while the testicular artery supplies the testis and epididymis. The cremasteric artery arises from the inferior epigastric artery, and the pampiniform plexus is a venous plexus that drains into the right or left testicular vein. The sympathetic nerve fibers lie on the arteries, while the parasympathetic fibers lie on the vas. The genital branch of the genitofemoral nerve supplies the cremaster. Lymphatic vessels drain to lumbar and para-aortic nodes.

Polycystic ovary syndrome leads to anovulation with normal levels of FSH and estrogen, known as normogonadotropic normoestrogenic anovulation. LH levels may be elevated or normal in this condition.

Hypogonadotropic hypogonadal anovulation is caused by hypopituitarism or hyperprolactinemia, resulting in low levels of gonadotropins and estrogen. However, hyperprolactinemia can be ruled out based on gonadotropin and estrogen levels alone.

Hypothalamic amenorrhea is a functional cause of hypogonadotropic hypogonadal anovulation, often due to factors such as low BMI, stress, or excessive exercise.

Understanding Ovulation Induction and Its Categories

Ovulation induction is a common treatment for couples who have difficulty conceiving naturally due to ovulation disorders. The process of ovulation requires a balance of hormones and feedback loops between the hypothalamus, pituitary gland, and ovaries. Anovulation can occur due to alterations in this balance, which can be classified into three categories: hypogonadotropic hypogonadal anovulation, normogonadotropic normoestrogenic anovulation, and hypergonadotropic hypoestrogenic anovulation. The goal of ovulation induction is to induce mono-follicular development and subsequent ovulation, leading to a singleton pregnancy.

There are various forms of ovulation induction, starting with the least invasive and simplest management option first. Exercise and weight loss are typically the first-line treatment for patients with polycystic ovarian syndrome, as ovulation can spontaneously return with even a modest 5% weight loss. Letrozole is now considered the first-line medical therapy for patients with PCOS due to its reduced risk of adverse effects on endometrial and cervical mucous compared to clomiphene citrate. Clomiphene citrate is a selective estrogen receptor modulator that acts primarily at the hypothalamus, blocking the negative feedback effect of estrogens. Gonadotropin therapy tends to be the treatment used mostly for women with hypogonadotropic hypogonadism.

One potential side effect of ovulation induction is ovarian hyperstimulation syndrome (OHSS), which can be life-threatening if not identified and managed promptly. OHSS occurs when ovarian enlargement with multiple cystic spaces form, and an increase in the permeability of capillaries leads to a fluid shift from the intravascular to the extra-vascular space. The severity of OHSS varies, with the risk of severe OHSS occurring in less than 1% of all women undergoing ovarian induction. Management includes fluid and electrolyte replacement, anticoagulation therapy, abdominal ascitic paracentesis, and pregnancy termination to prevent further hormonal imbalances.

The woman’s history of molar pregnancy suggests choriocarcinoma as a potential complication. Bleeding lasting one month after vaginal trauma, vaginitis, or uterine atony is not normal. Endometrial cancer is unlikely in women of childbearing age.

Gestational trophoblastic disorders refer to a range of conditions that originate from the placental trophoblast. These disorders include complete hydatidiform mole, partial hydatidiform mole, and choriocarcinoma. Complete hydatidiform mole is a benign tumor of trophoblastic material that occurs when an empty egg is fertilized by a single sperm that duplicates its own DNA, resulting in all 46 chromosomes being of paternal origin. Symptoms of this disorder include bleeding in the first or early second trimester, exaggerated pregnancy symptoms, a large uterus for dates, and high levels of human chorionic gonadotropin (hCG) in the blood. Hypertension and hyperthyroidism may also be present. Urgent referral to a specialist center is necessary, and evacuation of the uterus is performed. Effective contraception is recommended to avoid pregnancy in the next 12 months. About 2-3% of cases may progress to choriocarcinoma. In partial mole, a normal haploid egg may be fertilized by two sperms or one sperm with duplication of paternal chromosomes, resulting in DNA that is both maternal and paternal in origin. Fetal parts may be visible, and the condition is usually triploid.

During pregnancy, the development of carbohydrate intolerance is referred to as gestational diabetes mellitus. To diagnose this condition, an OGTT is typically performed at 28 weeks, although it may be done earlier for those at higher risk (such as those of Asian or Afro-Caribbean ethnicity, with a BMI over 30, a history of stillbirth, or family members with diabetes). Diabetes during pregnancy can increase the likelihood of various complications, including macrosomia, polyhydramnios, shoulder dystocia, congenital heart defects, neural tube defects, and neonatal hypoglycemia. Ebstein’s anomaly of the heart can occur as a result of lithium use during pregnancy, while prolonged rupture of membranes during pregnancy can lead to neonatal infection.

Gestational diabetes is a common medical disorder that affects around 4% of pregnancies. It can develop during pregnancy or be a pre-existing condition. According to NICE, 87.5% of cases are gestational diabetes, 7.5% are type 1 diabetes, and 5% are type 2 diabetes. Risk factors for gestational diabetes include a BMI of > 30 kg/m², previous gestational diabetes, a family history of diabetes, and family origin with a high prevalence of diabetes. Screening for gestational diabetes involves an oral glucose tolerance test (OGTT), which should be performed as soon as possible after booking and at 24-28 weeks if the first test is normal.

To diagnose gestational diabetes, NICE recommends using the following thresholds: fasting glucose is >= 5.6 mmol/L or 2-hour glucose is >= 7.8 mmol/L. Newly diagnosed women should be seen in a joint diabetes and antenatal clinic within a week and taught about self-monitoring of blood glucose. Advice about diet and exercise should be given, and if glucose targets are not met within 1-2 weeks of altering diet/exercise, metformin should be started. If glucose targets are still not met, insulin should be added to the treatment plan.

For women with pre-existing diabetes, weight loss is recommended for those with a BMI of > 27 kg/m^2. Oral hypoglycaemic agents, apart from metformin, should be stopped, and insulin should be commenced. Folic acid 5 mg/day should be taken from pre-conception to 12 weeks gestation, and a detailed anomaly scan at 20 weeks, including four-chamber view of the heart and outflow tracts, should be performed. Tight glycaemic control reduces complication rates, and retinopathy should be treated as it can worsen during pregnancy.

Targets for self-monitoring of pregnant women with diabetes include a fasting glucose level of 5.3 mmol/l and a 1-hour or 2-hour glucose level after meals of 7.8 mmol/l or 6.4 mmol/l, respectively. It is important to manage gestational diabetes and pre-existing diabetes during pregnancy to reduce the risk of complications for both the mother and baby.

The Broad ligament is where the Fallopian tubes are located. If a tubal ectopic pregnancy is detected with a fetal heartbeat, the recommended treatment is a laparoscopic salpingectomy. This surgical procedure involves removing the affected Fallopian tube by accessing it within the Broad ligament. However, if there are other risk factors for infertility, a laparoscopic salpingotomy may be performed instead.

On the other hand, the Cardinal ligament contains the uterine vessels and is not involved in ectopic pregnancy. It may be operated on in cases of uterine fibroids through a laparoscopic myomectomy.

The Ovarian ligament attaches the ovaries to the uterus but does not contain any structures. Meanwhile, the Round ligament attaches the uterine fundus to the labia majora but also does not contain any structures.

Pelvic Ligaments and their Connections

Pelvic ligaments are structures that connect various organs within the female reproductive system to the pelvic wall. These ligaments play a crucial role in maintaining the position and stability of these organs. There are several types of pelvic ligaments, each with its own unique function and connection.

The broad ligament connects the uterus, fallopian tubes, and ovaries to the pelvic wall, specifically the ovaries. The round ligament connects the uterine fundus to the labia majora, but does not connect to any other structures. The cardinal ligament connects the cervix to the lateral pelvic wall and is responsible for supporting the uterine vessels. The suspensory ligament of the ovaries connects the ovaries to the lateral pelvic wall and supports the ovarian vessels. The ovarian ligament connects the ovaries to the uterus, but does not connect to any other structures. Finally, the uterosacral ligament connects the cervix and posterior vaginal dome to the sacrum, but does not connect to any other structures.

Overall, pelvic ligaments are essential for maintaining the proper position and function of the female reproductive organs. Understanding the connections between these ligaments and the structures they support is crucial for diagnosing and treating any issues that may arise.

Following ovulation, the body temperature increases, which can be used as a method of behavioural contraception. By measuring and plotting the temperature each day, patients can identify their fertile window and use alternative contraception during this time. However, this method is less effective than hormonal contraception. The rise in temperature is due to the increase in progesterone levels, which is maintained after fertilisation. The initiation of the follicular phase and menses do not cause a rapid rise in temperature, as the progesterone levels are typically low during these phases. A peak in oestrogen does not affect the body temperature.

Phases of the Menstrual Cycle

The menstrual cycle is a complex process that can be divided into four phases: menstruation, follicular phase, ovulation, and luteal phase. During the follicular phase, a number of follicles develop in the ovaries, with one follicle becoming dominant around the mid-follicular phase. At the same time, the endometrium undergoes proliferation. This phase is characterized by a rise in follicle-stimulating hormone (FSH), which results in the development of follicles that secrete oestradiol. When the egg has matured, it secretes enough oestradiol to trigger the acute release of luteinizing hormone (LH), which leads to ovulation.

During the luteal phase, the corpus luteum secretes progesterone, which causes the endometrium to change to a secretory lining. If fertilization does not occur, the corpus luteum will degenerate, and progesterone levels will fall. Oestradiol levels also rise again during the luteal phase. Cervical mucus thickens and forms a plug across the external os following menstruation. Just prior to ovulation, the mucus becomes clear, acellular, low viscosity, and stretchy. Under the influence of progesterone, it becomes thick, scant, and tacky. Basal body temperature falls prior to ovulation due to the influence of oestradiol and rises following ovulation in response to higher progesterone levels. Understanding the phases of the menstrual cycle is important for women’s health and fertility.

The proliferative phase is characterized by the thickening of the endometrium due to the presence of oestrogen secreted by the mature follicle.

As oestrogen levels rise during this phase, the endometrium undergoes proliferation and thickening. Tubular glands extend and spiral arteries form, leading to increased vascularity. Additionally, oestrogen stimulates progesterone receptors on endometrial cells.

Phases of the Menstrual Cycle

The menstrual cycle is a complex process that can be divided into four phases: menstruation, follicular phase, ovulation, and luteal phase. During the follicular phase, a number of follicles develop in the ovaries, with one follicle becoming dominant around the mid-follicular phase. At the same time, the endometrium undergoes proliferation. This phase is characterized by a rise in follicle-stimulating hormone (FSH), which results in the development of follicles that secrete oestradiol. When the egg has matured, it secretes enough oestradiol to trigger the acute release of luteinizing hormone (LH), which leads to ovulation.

During the luteal phase, the corpus luteum secretes progesterone, which causes the endometrium to change to a secretory lining. If fertilization does not occur, the corpus luteum will degenerate, and progesterone levels will fall. Oestradiol levels also rise again during the luteal phase. Cervical mucus thickens and forms a plug across the external os following menstruation. Just prior to ovulation, the mucus becomes clear, acellular, low viscosity, and stretchy. Under the influence of progesterone, it becomes thick, scant, and tacky. Basal body temperature falls prior to ovulation due to the influence of oestradiol and rises following ovulation in response to higher progesterone levels. Understanding the phases of the menstrual cycle is important for women’s health and fertility.

A pregnant woman who has 3 risk factors should receive LMWH from 28 weeks until 6 weeks after giving birth. If she has more than 3 risk factors, she should start LMWH immediately and continue until 6 weeks postnatal.

The risk factors for thromboprophylaxis include age over 35, a body mass index over 30, parity over 3, smoking, gross varicose veins, current pre-eclampsia, immobility, family history of unprovoked VTE, low risk thrombophilia, multiple pregnancy, and IVF pregnancy.

In this particular case, the woman has 4 risk factors, including being 36 years old, a smoker, having a parity over 3, and a body mass index of 33. Therefore, she needs to begin taking low molecular weight heparin immediately and continue until 6 weeks after giving birth.

While all pregnant women should be advised to stay mobile and hydrated, this woman requires medical treatment due to her increased risk factors.

Pregnancy increases the risk of developing venous thromboembolism (VTE), which is why it is important to assess a woman’s individual risk during pregnancy and take appropriate prophylactic measures. A risk assessment should be conducted at the time of booking and on any subsequent hospital admission. Women with a previous VTE history are automatically considered high risk and require low molecular weight heparin throughout the antenatal period, along with input from experts. Women at intermediate risk due to hospitalization, surgery, comorbidities, or thrombophilia should also be considered for antenatal prophylactic low molecular weight heparin.

The risk assessment at booking should include factors that increase the likelihood of developing VTE, such as age over 35, body mass index over 30, parity over 3, smoking, gross varicose veins, current pre-eclampsia, immobility, family history of unprovoked VTE, low-risk thrombophilia, multiple pregnancy, and IVF pregnancy. If a woman has four or more risk factors, immediate treatment with low molecular weight heparin should be initiated and continued until six weeks postnatal. If a woman has three risk factors, low molecular weight heparin should be initiated from 28 weeks and continued until six weeks postnatal.

If a diagnosis of DVT is made shortly before delivery, anticoagulation treatment should be continued for at least three months, as in other patients with provoked DVTs. Low molecular weight heparin is the preferred treatment for VTE prophylaxis in pregnancy, while Direct Oral Anticoagulants (DOACs) and warfarin should be avoided. By taking these measures, the risk of developing VTE during pregnancy can be reduced.

The most probable cause of the woman’s pain during defecation is bleeding in either the bowel or the pouch of Douglas. Since the only given option is the latter, it is the correct answer. Bleeding into the ovaries can result in ‘chocolate cysts’ that can be observed during laparoscopy. None of the other options mentioned provide anatomical landmarks that could lead to bleeding in the spaces and pain during defecation.

Endometriosis is a condition where endometrial tissue grows outside of the uterus, affecting around 10% of women of reproductive age. Symptoms include chronic pelvic pain, painful periods, pain during sex, and subfertility. Diagnosis is made through laparoscopy, and treatment depends on the severity of symptoms. First-line treatments include NSAIDs and hormonal treatments such as the combined oral contraceptive pill or progestogens. If these do not improve symptoms or fertility is a priority, referral to secondary care may be necessary. Treatment options in secondary care include GnRH analogues and surgery, with laparoscopic excision or ablation of endometriosis plus adhesiolysis recommended for women trying to conceive. Ovarian cystectomy may also be necessary for endometriomas.

Phenytoin is a well-established cause of folic acid deficiency, along with excess alcohol, methotrexate, and pregnancy. Menopause is not typically associated with folate deficiency, but rather a deficiency in vitamin B12. Smoking tobacco and laxative abuse are not known to cause folate deficiency. It is important to note that vitamin B12 and folic acid are linked in megaloblastic anemia, but administering vitamin B12 injections does not cause folate deficiency. Additionally, it is crucial to correct low vitamin B12 levels before supplementing with folate to avoid subacute combined degeneration of the spinal cord.

Folic Acid: Importance, Deficiency, and Prevention

Folic acid is a vital nutrient that is converted to tetrahydrofolate (THF) in the body. THF plays a crucial role in transferring 1-carbon units to essential substrates involved in DNA and RNA synthesis. Green, leafy vegetables are a good source of folic acid. However, certain medications like phenytoin and methotrexate, pregnancy, and alcohol excess can cause folic acid deficiency. This deficiency can lead to macrocytic, megaloblastic anemia and neural tube defects.

To prevent neural tube defects during pregnancy, all women should take 400mcg of folic acid until the 12th week of pregnancy. Women at higher risk of conceiving a child with a neural tube defect should take 5 mg of folic acid from before conception until the 12th week of pregnancy. Women are considered higher risk if either partner has a neural tube defect, they have had a previous pregnancy affected by a neural tube defect, or they have a family history of a neural tube defect. Additionally, women with antiepileptic drugs or coeliac disease, diabetes, or thalassaemia trait, and those who are obese (BMI of 30 kg/m2 or more) are also at higher risk and should take the higher dose of folic acid.

Causes of Right Iliac Fossa Pain in Women

Right iliac fossa pain in women can be caused by various conditions such as mittelschmerz, appendicitis, and ectopic pregnancy. However, in the case of a young woman who is seven weeks past her last period, ectopic pregnancy is highly suspected. This condition occurs when a fertilized egg implants outside the uterus, usually in the fallopian tube.

To confirm or rule out ectopic pregnancy, the most appropriate initial test would be a pregnancy test. This test detects the presence of human chorionic gonadotropin (hCG), a hormone produced by the placenta after implantation. If the test is positive, further evaluation such as ultrasound and blood tests may be necessary to determine the location of the pregnancy and the appropriate management. It is important to seek medical attention promptly if experiencing RIF pain, as delay in diagnosis and treatment of ectopic pregnancy can lead to serious complications.

Smoking while pregnant has been linked to the birth of a Small for Gestational Age baby. This is indicated by the baby’s birth weight being below the 10th percentile and fetal measurements suggesting asymmetrical intrauterine growth restriction (IUGR), with the head circumference being significantly higher than the abdominal circumference and femur length. Maternal smoking is a possible cause of the baby’s small size, as it has been associated with reduced birth weight and asymmetrical IUGR. Multiple gestation is a known risk factor for fetal growth restriction, but singleton gestation is not. Maternal rubella infection and advanced maternal age may also cause small for gestational age babies, but these are less likely causes in this case as the mother’s immunisations are up to date and she is only 23 years old.

Small for Gestational Age (SGA) is a statistical definition used to describe babies who are smaller than expected for their gestational age. Although there is no universally agreed percentile, the 10th percentile is often used, meaning that 10% of normal babies will be below this threshold. SGA can be determined either antenatally or postnatally. There are two types of SGA: symmetrical and asymmetrical. Symmetrical SGA occurs when the fetal head circumference and abdominal circumference are equally small, while asymmetrical SGA occurs when the abdominal circumference slows relative to the increase in head circumference.

There are various causes of SGA, including incorrect dating, constitutionally small (normal) babies, and abnormal fetuses. Symmetrical SGA is more common and can be caused by idiopathic factors, race, sex, placental insufficiency, pre-eclampsia, chromosomal and congenital abnormalities, toxins such as smoking and heroin, and infections such as CMV, parvovirus, rubella, syphilis, and toxoplasmosis. Asymmetrical SGA is less common and can be caused by toxins such as alcohol, cigarettes, and heroin, chromosomal and congenital abnormalities, and infections.

The management of SGA depends on the type and cause. For symmetrical SGA, most cases represent the lower limits of the normal range and require fortnightly ultrasound growth assessments to demonstrate normal growth rates. Pathological causes should be ruled out by checking maternal blood for infections and searching the fetus carefully with ultrasound for markers of chromosomal abnormality. Asymmetrical SGA also requires fortnightly ultrasound growth assessments, as well as biophysical profiles and Doppler waveforms from umbilical circulation to look for absent end-diastolic flow. If results are sub-optimal, delivery may be considered.

Monozygotic twins with one chorion and two amnions are the result of division between days 4 and 8 after fertilization. This type of twinning has diamniotic, monochorionic placentation. Division between days 8 and 12 after fertilization leads to monozygotic twins with monoamniotic, monochorionic placentation, while fertilization of two separate eggs with two separate sperm results in dizygotic twins with diamniotic, dichorionic placentation. It’s important to note that division between days 4 and 8 after fertilization does not result in dizygotic twins.

Twin Pregnancies: Incidence, Types, and Complications

Twin pregnancies occur in approximately 1 out of 105 pregnancies, with the majority being dizygotic or non-identical twins. Monozygotic or identical twins, on the other hand, develop from a single ovum that has divided to form two embryos. However, monoamniotic monozygotic twins are associated with increased risks of spontaneous miscarriage, perinatal mortality rate, malformations, intrauterine growth restriction, prematurity, and twin-to-twin transfusions. The incidence of dizygotic twins is increasing due to infertility treatment, and predisposing factors include previous twins, family history, increasing maternal age, multigravida, induced ovulation, in-vitro fertilisation, and race, particularly Afro-Caribbean.

Antenatal complications of twin pregnancies include polyhydramnios, pregnancy-induced hypertension, anaemia, and antepartum haemorrhage. Fetal complications include perinatal mortality, prematurity, light-for-date babies, and malformations, especially in monozygotic twins. Labour complications may also arise, such as postpartum haemorrhage, malpresentation, cord prolapse, and entanglement.

Management of twin pregnancies involves rest, ultrasound for diagnosis and monthly checks, additional iron and folate, more antenatal care, and precautions during labour, such as having two obstetricians present. Most twins deliver by 38 weeks, and if longer, most are induced at 38-40 weeks. Overall, twin pregnancies require close monitoring and management to ensure the best possible outcomes for both mother and babies.

Understanding Ovarian Cancer: Risk Factors, Symptoms, and Management

Ovarian cancer is a type of cancer that affects women, with the peak age of incidence being 60 years. It is the fifth most common malignancy in females and carries a poor prognosis due to late diagnosis. Around 90% of ovarian cancers are epithelial in origin, with 70-80% of cases being due to serous carcinomas. Interestingly, recent studies suggest that the distal end of the fallopian tube is often the site of origin of many ‘ovarian’ cancers.

There are several risk factors associated with ovarian cancer, including a family history of mutations of the BRCA1 or the BRCA2 gene, early menarche, late menopause, and nulliparity. Clinical features of ovarian cancer are notoriously vague and can include abdominal distension and bloating, abdominal and pelvic pain, urinary symptoms, early satiety, and diarrhea.

To diagnose ovarian cancer, a CA125 test is usually done initially. If the CA125 level is raised, an urgent ultrasound scan of the abdomen and pelvis should be ordered. However, a CA125 should not be used for screening for ovarian cancer in asymptomatic women. Diagnosis is difficult and usually involves diagnostic laparotomy.

Management of ovarian cancer usually involves a combination of surgery and platinum-based chemotherapy. The prognosis for ovarian cancer is poor, with 80% of women having advanced disease at presentation and the all stage 5-year survival being 46%. It is traditionally taught that infertility treatment increases the risk of ovarian cancer, as it increases the number of ovulations. However, recent evidence suggests that there is not a significant link. The combined oral contraceptive pill reduces the risk (fewer ovulations) as does having many pregnancies.

Anatomy of the Scrotum and Testes

The scrotum is composed of skin and dartos fascia, with an arterial supply from the anterior and posterior scrotal arteries. It is also the site of lymphatic drainage to the inguinal lymph nodes. The testes are surrounded by the tunica vaginalis, a closed peritoneal sac, with the parietal layer adjacent to the internal spermatic fascia. The testicular arteries arise from the aorta, just below the renal arteries, and the pampiniform plexus drains into the testicular veins. The left testicular vein drains into the left renal vein, while the right testicular vein drains into the inferior vena cava. Lymphatic drainage occurs to the para-aortic nodes.

The spermatic cord is formed by the vas deferens and is covered by the internal spermatic fascia, cremasteric fascia, and external spermatic fascia. The cord contains the vas deferens, testicular artery, artery of vas deferens, cremasteric artery, pampiniform plexus, sympathetic nerve fibers, genital branch of the genitofemoral nerve, and lymphatic vessels. The vas deferens transmits sperm and accessory gland secretions, while the testicular artery supplies the testis and epididymis. The cremasteric artery arises from the inferior epigastric artery, and the pampiniform plexus is a venous plexus that drains into the right or left testicular vein. The sympathetic nerve fibers lie on the arteries, while the parasympathetic fibers lie on the vas. The genital branch of the genitofemoral nerve supplies the cremaster. Lymphatic vessels drain to lumbar and para-aortic nodes.

The presence of ↑ HCG, ↓ PAPP-A, and a thickened nuchal translucency is indicative of Down’s syndrome. The combined screening test, which includes an ultrasound scan and blood test, is used to assess the risk of the fetus having Down’s syndrome, Edwards’ syndrome, and Patau’s syndrome. However, a diagnostic test such as amniocentesis or chorionic villus sampling is required to confirm the diagnosis. Advanced maternal age is also a significant risk factor for Down’s syndrome. The answer choices ‘↑ HCG, ↑ PAPP-A, increased amount of nuchal fluid’, ‘↑ HCG, ↓ PAPP-A, normal amount of nuchal fluid’, and ‘↓ HCG, ↓ PAPP-A, decreased amount of nuchal fluid’ are incorrect as they do not match the typical indicators of Down’s syndrome.

NICE updated guidelines on antenatal care in 2021, recommending the combined test for screening for Down’s syndrome between 11-13+6 weeks. The quadruple test should be offered between 15-20 weeks for women who book later in pregnancy. Results of both tests return either a ‘lower chance’ or ‘higher chance’ result. If a woman receives a ‘higher chance’ result, she will be offered a second screening test (NIPT) or a diagnostic test. NIPT analyzes cell-free fetal DNA from placental cells in the mother’s blood and has high sensitivity and specificity for detecting chromosomal abnormalities, with private companies offering screening from 10 weeks gestation.

During pregnancy, the depth of breathing increases, which is known as tidal volume. This is caused by progesterone relaxing the intercostal muscles and diaphragm, allowing for greater lung inflation during breathing. This is a normal change and is not caused by oestrogen, which typically causes other physical changes during pregnancy such as spider naevi, palmar erythema, and skin pigmentation.

Other physiological changes that occur during pregnancy include increased uterine size, cervical ectropion, increased vaginal discharge, increased plasma volume, anaemia, increased white blood cell count, platelets, ESR, cholesterol, and fibrinogen, as well as decreased albumin, urea, and creatinine. Progesterone-related effects during pregnancy include decreased blood pressure, constipation, ureteral dilation, bladder relaxation, biliary stasis, and increased tidal volume.

During pregnancy, a woman’s body undergoes various physiological changes. The cardiovascular system experiences an increase in stroke volume, heart rate, and cardiac output, while systolic blood pressure remains unchanged and diastolic blood pressure decreases in the first and second trimesters before returning to normal levels by term. The enlarged uterus may cause issues with venous return, leading to ankle swelling, supine hypotension, and varicose veins.

The respiratory system sees an increase in pulmonary ventilation and tidal volume, with oxygen requirements only increasing by 20%. This can lead to a sense of dyspnea due to over-breathing and a fall in pCO2. The basal metabolic rate also increases, potentially due to increased thyroxine and adrenocortical hormones.

Maternal blood volume increases by 30%, with red blood cells increasing by 20% and plasma increasing by 50%, leading to a decrease in hemoglobin levels. Coagulant activity increases slightly, while fibrinolytic activity decreases. Platelet count falls, and white blood cell count and erythrocyte sedimentation rate rise.

The urinary system experiences an increase in blood flow and glomerular filtration rate, with elevated sex steroid levels leading to increased salt and water reabsorption and urinary protein losses. Trace glycosuria may also occur.

Calcium requirements increase during pregnancy, with gut absorption increasing substantially due to increased 1,25 dihydroxy vitamin D. Serum levels of calcium and phosphate may fall, but ionized calcium levels remain stable. The liver experiences an increase in alkaline phosphatase and a decrease in albumin levels.

The uterus undergoes significant changes, increasing in weight from 100g to 1100g and transitioning from hyperplasia to hypertrophy. Cervical ectropion and discharge may increase, and Braxton-Hicks contractions may occur in late pregnancy. Retroversion may lead to retention in the first trimester but usually self-corrects.

During pregnancy, the main contributor to the increased cardiac output is the increased stroke volume, which is caused by the activation of the renin-angiotensin system and the subsequent increase in plasma volume. Although the heart rate also increases slightly, it is not as significant as the increase in stroke volume. Therefore, the major contributor to the increased cardiac output is the stroke volume.

The statements ‘decreased heart rate’ and ‘increased peripheral resistance’ are incorrect. In fact, peripheral resistance decreases due to progesterone, which contributes to the normal decrease in blood pressure during pregnancy. Peripheral resistance is more concerned with blood pressure.

Pregnancy also causes various physiological changes, including increased uterine size, cervical ectropion, reduced cervical collagen, and increased vaginal discharge. Cardiovascular and haemodynamic changes include increased plasma volume, anaemia, increased white cell count, platelets, ESR, cholesterol, and fibrinogen, as well as decreased albumin, urea, and creatinine. Progesterone-related effects, such as muscle relaxation, can cause decreased blood pressure, constipation, ureteral dilation, bladder relaxation, biliary stasis, and increased tidal volume.

During pregnancy, a woman’s body undergoes various physiological changes. The cardiovascular system experiences an increase in stroke volume, heart rate, and cardiac output, while systolic blood pressure remains unchanged and diastolic blood pressure decreases in the first and second trimesters before returning to normal levels by term. The enlarged uterus may cause issues with venous return, leading to ankle swelling, supine hypotension, and varicose veins.

The respiratory system sees an increase in pulmonary ventilation and tidal volume, with oxygen requirements only increasing by 20%. This can lead to a sense of dyspnea due to over-breathing and a fall in pCO2. The basal metabolic rate also increases, potentially due to increased thyroxine and adrenocortical hormones.

Maternal blood volume increases by 30%, with red blood cells increasing by 20% and plasma increasing by 50%, leading to a decrease in hemoglobin levels. Coagulant activity increases slightly, while fibrinolytic activity decreases. Platelet count falls, and white blood cell count and erythrocyte sedimentation rate rise.

The urinary system experiences an increase in blood flow and glomerular filtration rate, with elevated sex steroid levels leading to increased salt and water reabsorption and urinary protein losses. Trace glycosuria may also occur.

Calcium requirements increase during pregnancy, with gut absorption increasing substantially due to increased 1,25 dihydroxy vitamin D. Serum levels of calcium and phosphate may fall, but ionized calcium levels remain stable. The liver experiences an increase in alkaline phosphatase and a decrease in albumin levels.

The uterus undergoes significant changes, increasing in weight from 100g to 1100g and transitioning from hyperplasia to hypertrophy. Cervical ectropion and discharge may increase, and Braxton-Hicks contractions may occur in late pregnancy. Retroversion may lead to retention in the first trimester but usually self-corrects.

To test for ovulation in women with regular cycles, Day 21 progesterone (mid-luteal cycle progesterone) is used. However, for those with irregular cycles, progesterone should be tested a week before the predicted menstruation. Ovulation is necessary for fertilization to occur, as it indicates the release of an egg.

Oestrogen and Progesterone: Their Sources and Functions

Oestrogen and progesterone are two important hormones in the female body. Oestrogen is primarily produced by the ovaries, but can also be produced by the placenta and blood via aromatase. Its functions include promoting the development of genitalia, causing the LH surge, and increasing hepatic synthesis of transport proteins. It also upregulates oestrogen, progesterone, and LH receptors, and is responsible for female fat distribution. On the other hand, progesterone is produced by the corpus luteum, placenta, and adrenal cortex. Its main function is to maintain the endometrium and pregnancy, as well as to thicken cervical mucous and decrease myometrial excitability. It also increases body temperature and is responsible for spiral artery development.

It is important to note that these hormones work together in regulating the menstrual cycle and preparing the body for pregnancy. Oestrogen promotes the proliferation of the endometrium, while progesterone maintains it. Without these hormones, the menstrual cycle and pregnancy would not be possible. Understanding the sources and functions of oestrogen and progesterone is crucial in diagnosing and treating hormonal imbalances and reproductive disorders.

LH binds to LH receptors on thecal cells, stimulating the production of androstenedione. This androgen is then converted into oestradiol by aromatase in the granulosa cells.

The process of follicle development can be divided into several stages. Primordial follicles contain an oocyte and granulosa cells. Primary follicles are characterized by the development of the zona pellucida and proliferation of granulosa cells. Pre-antral follicles develop a theca layer. Mature or Graafian follicles are marked by the presence of an antrum. Finally, the corpus luteum forms after the oocyte is released due to enzymatic breakdown of the follicular wall.

It is important to note that FSH, progesterone, testosterone, and oestrogen receptors are not involved in the production of oestradiol from androstenedione.

Anatomy of the Ovarian Follicle

The ovarian follicle is a complex structure that plays a crucial role in female reproductive function. It consists of several components, including granulosa cells, the zona pellucida, the theca, the antrum, and the cumulus oophorus.

Granulosa cells are responsible for producing oestradiol, which is essential for follicular development. Once the follicle becomes the corpus luteum, granulosa lutein cells produce progesterone, which is necessary for embryo implantation. The zona pellucida is a membrane that surrounds the oocyte and contains the protein ZP3, which is responsible for sperm binding.

The theca produces androstenedione, which is converted into oestradiol by granulosa cells. The antrum is a fluid-filled portion of the follicle that marks the transition of a primary oocyte into a secondary oocyte. Finally, the cumulus oophorus is a cluster of cells surrounding the oocyte that must be penetrated by spermatozoa for fertilisation to occur.

Understanding the anatomy of the ovarian follicle is essential for understanding female reproductive function and fertility. Each component plays a unique role in the development and maturation of the oocyte, as well as in the processes of fertilisation and implantation.

Fertilization happens when a sperm reaches an egg that has been released during ovulation. The process begins with the sperm penetrating the outer layer of the egg, called the corona radiata, using enzymes in the plasma membrane of its head. These enzymes bind to receptors on the next inner layer of the egg, called the zona pellucida, triggering the acrosome reaction. This reaction causes the acrosomal hydrolytic enzymes to digest the zona pellucida, creating a pathway to the egg’s plasma membrane. The sperm then enters the egg’s cytoplasm, and the two cells fuse together to form a diploid zygote. The sperm also stimulates the release of calcium ions from the cortical granules of the egg, which inactivate the receptors on the zona pellucida to prevent polyspermy. After fertilization, the zygote undergoes rapid mitotic cell divisions to form an embryo.

The Process of Fertilisation

Fertilisation is the process by which a sperm cell reaches and penetrates an egg cell that has been released during ovulation. The first step involves the sperm penetrating the corona radiata, which is the outer layer of the ovum, using enzymes in the plasma membrane of the sperm’s head. These enzymes bind to the ZP3 receptors on the zona pellucida, which is the next inner layer of the ovum, triggering the acrosome reaction. This reaction involves the acrosomal hydrolytic enzymes digesting the zona pellucida, creating a pathway to the ovum plasma membrane.

Once the sperm enters the ovum cytoplasm, the two cells fuse together, resulting in the formation of a diploid zygote. The sperm also stimulates the release of calcium ions from the cortical granules of the ovum, which inactivate the ZP3 receptors to prevent polyspermy. After fertilisation, rapid mitotic cell divisions occur, resulting in the production of an embryo.

In summary, fertilisation is a complex process that involves the penetration of the ovum by the sperm, the fusion of the two cells, and the subsequent development of the zygote into an embryo.

The likely cause of this patient’s amenorrhoea and galactorrhoea is a prolactinoma, which inhibits the secretion of GnRH and leads to low levels of oestrogen. Further tests, including a urinary pregnancy test and blood tests for various hormones, should be conducted to confirm the diagnosis. Asherman’s syndrome, intraductal papilloma, and pregnancy are less likely causes, as they do not present with the same symptoms or do not fit the patient’s reported history.

Understanding Amenorrhoea: Causes, Investigations, and Management

Amenorrhoea is a condition characterized by the absence of menstrual periods. It can be classified into two types: primary and secondary. Primary amenorrhoea occurs when menstruation fails to start by the age of 15 in girls with normal secondary sexual characteristics or by the age of 13 in girls with no secondary sexual characteristics. On the other hand, secondary amenorrhoea is the cessation of menstruation for 3-6 months in women with previously normal and regular menses or 6-12 months in women with previous oligomenorrhoea.

The causes of amenorrhoea vary depending on the type. Primary amenorrhoea may be caused by gonadal dysgenesis, testicular feminization, congenital malformations of the genital tract, functional hypothalamic amenorrhoea, congenital adrenal hyperplasia, imperforate hymen, hypothalamic amenorrhoea, polycystic ovarian syndrome, hyperprolactinemia, premature ovarian failure, and thyrotoxicosis. Meanwhile, secondary amenorrhoea may be caused by stress, excessive exercise, PCOS, Sheehan’s syndrome, Asherman’s syndrome, and other underlying medical conditions.

To diagnose amenorrhoea, initial investigations may include pregnancy tests, full blood count, urea & electrolytes, coeliac screen, thyroid function tests, gonadotrophins, prolactin, and androgen levels. Management of amenorrhoea involves treating the underlying cause. For primary amenorrhoea, it is important to investigate and treat any underlying cause. For secondary amenorrhoea, it is important to exclude pregnancy, lactation, and menopause and treat the underlying cause accordingly. Women with primary ovarian insufficiency due to gonadal dysgenesis may benefit from hormone replacement therapy to prevent osteoporosis and other complications.

In conclusion, amenorrhoea is a condition that requires proper diagnosis and management. Understanding the causes and appropriate investigations can help in providing the necessary treatment and care for women experiencing this condition.

Androgens play a crucial role in the development of male reproductive organs, as they stimulate the formation of Wolffian ducts that eventually give rise to the vas deferens, epididymis, and seminal vesicles. In the absence of androgen activity, the Wolffian ducts break down, leading to the failure of male reproductive organ development. Additionally, Sertoli cells produce anti-Mullerian hormone, which prevents the formation of female internal genitalia. The lack of androgen effects also results in the absence of masculine characteristics in the external genitalia.

Understanding Androgen Insensitivity Syndrome

Androgen insensitivity syndrome is a genetic condition that affects individuals with an XY genotype, causing them to develop a female phenotype due to their body’s resistance to testosterone. This condition was previously known as testicular feminization syndrome. Common features of this condition include primary amenorrhea, little to no pubic and axillary hair, undescended testes leading to groin swellings, and breast development due to the conversion of testosterone to estrogen.

Diagnosis of androgen insensitivity syndrome can be done through a buccal smear or chromosomal analysis, which reveals a 46XY genotype. After puberty, testosterone levels in individuals with this condition are typically in the high-normal to slightly elevated range for postpubertal boys.

Management of androgen insensitivity syndrome involves counseling and raising the child as female. Bilateral orchidectomy is recommended to reduce the risk of testicular cancer due to undescended testes. Additionally, estrogen therapy may be used to promote the development of secondary sexual characteristics. Understanding androgen insensitivity syndrome is crucial for proper diagnosis and management of affected individuals.

Gestational diabetes is the correct answer as it can result in foetal macrosomia, which is caused by insulin resistance promoting fat storage, and polyhydramnios, which is caused by foetal polyuria.

While maternal obesity may cause macrosomia, it does not necessarily lead to polyhydramnios.

Foetal gut atresia is a condition where part of the intestine is narrowed or absent, which can make it difficult for the foetus to ingest substances like amniotic fluid. This can result in excess amniotic fluid and polyhydramnios, but not macrosomia.

Hydrops fetalis may cause polyhydramnios, but it does not necessarily lead to macrosomia. However, it can cause hepatosplenomegaly.

Maternal hypercalcaemia may cause polyhydramnios, but it does not necessarily lead to macrosomia.

Gestational diabetes is a common medical disorder that affects around 4% of pregnancies. It can develop during pregnancy or be a pre-existing condition. According to NICE, 87.5% of cases are gestational diabetes, 7.5% are type 1 diabetes, and 5% are type 2 diabetes. Risk factors for gestational diabetes include a BMI of > 30 kg/m², previous gestational diabetes, a family history of diabetes, and family origin with a high prevalence of diabetes. Screening for gestational diabetes involves an oral glucose tolerance test (OGTT), which should be performed as soon as possible after booking and at 24-28 weeks if the first test is normal.

To diagnose gestational diabetes, NICE recommends using the following thresholds: fasting glucose is >= 5.6 mmol/L or 2-hour glucose is >= 7.8 mmol/L. Newly diagnosed women should be seen in a joint diabetes and antenatal clinic within a week and taught about self-monitoring of blood glucose. Advice about diet and exercise should be given, and if glucose targets are not met within 1-2 weeks of altering diet/exercise, metformin should be started. If glucose targets are still not met, insulin should be added to the treatment plan.

For women with pre-existing diabetes, weight loss is recommended for those with a BMI of > 27 kg/m^2. Oral hypoglycaemic agents, apart from metformin, should be stopped, and insulin should be commenced. Folic acid 5 mg/day should be taken from pre-conception to 12 weeks gestation, and a detailed anomaly scan at 20 weeks, including four-chamber view of the heart and outflow tracts, should be performed. Tight glycaemic control reduces complication rates, and retinopathy should be treated as it can worsen during pregnancy.

Targets for self-monitoring of pregnant women with diabetes include a fasting glucose level of 5.3 mmol/l and a 1-hour or 2-hour glucose level after meals of 7.8 mmol/l or 6.4 mmol/l, respectively. It is important to manage gestational diabetes and pre-existing diabetes during pregnancy to reduce the risk of complications for both the mother and baby.